Element Materials Technology Iowa City Inc.
North Liberty, IA Doing business as JMI Laboratories
- UEI
- GAJDDSFFPD89
- CAGE
- 7RGU7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 345 Beaver Kreek Center, North Liberty, IA 52317, USA
- Website
- jmilabs.com
- Founded
- 2000
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 75N93019D00011; jones microbiology institute INC; A30: bacterial in vitro screening; to 75N93026F00001; can 8023349;… | National Institute of Allergy and Infectious Diseases | $65,000 | |
| In vitro screening for antibacterial activity against public health disease pathogens. | National Institute of Allergy and Infectious Diseases | $45,248 | |
| Determination of the in vitro inhibitory effect of experimental antibacterial substances against bacterial pathogens | National Institute of Allergy and Infectious Diseases | $342,000 | |
| Antimicrobial resistance laboratory services | Food and Drug Administration | $677,014 | |
| The contractor shall determine the in vitro minimal inhibitory concentration (MIC) of candidate products against a panel… | National Institute of Allergy and Infectious Diseases | $94,325 |
About Element Materials Technology Iowa City Inc.
Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, operates as a specialized microbiology laboratory providing in vitro antimicrobial resistance testing, minimum inhibitory concentration assays, and antibacterial screening services to federal health and research agencies as a prime contractor (95% of awards). The firm is a for-profit Subchapter S Corporation headquartered in North Liberty, Iowa, registered as a federal contractor since November 2016, with no SBA set-aside designations across its recent prime award portfolio—all work competes full-and-open on merit.
JMI Laboratories' customer concentration is tightly focused on Department of Health and Human Services components. The National Institute of Allergy and Infectious Diseases accounts for 12 awards and $33.4 million in combined potential value—97% of the portfolio—with the Food and Drug Administration (4 awards, $1.4 million), the National Cancer Institute (2 awards, $40 thousand), and the Office of the Assistant Secretary for Preparedness and Response (1 award) rounding out the full customer set. Both award-count and potential-value rankings track identically, reflecting NIAID's dominant share across both volume and dollars.
JMI Laboratories' capability footprint centers on in vitro antimicrobial activity assessments and resistance pharmacogenetics. Representative work includes a $570 thousand firm fixed-price delivery order from NIAID (May 2024) for determination of in vitro inhibitory effects of experimental antibacterial substances against bacterial pathogens; a $755.7 thousand NIAID delivery order (September 2021) for minimum inhibitory concentration testing of experimental compounds; a $1.122 million definitive contract with the FDA (September 2023) for interlaboratory studies of biological variability in broth microdilution MIC measurements; and a $112.4 thousand NIAID delivery order (August 2024) for in vitro screening and inhibitory-effect determination against public health disease pathogens. Work is performed exclusively at the North Liberty, Iowa facility.
JMI Laboratories places 11 task orders under the In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite-delivery/indefinite-quantity contract vehicle administered by NIAID, carrying $3.4 million in combined potential value. The vendor operates as a pure prime on federal services work and carries no named subcontractors in the recent award footprint. Activity peaked in 2023 (6 awards) and has declined to 2 awards in 2024 and 1 award in 2025; two awards totaling $1.2 million in combined potential value face ultimate completion within the next twenty-four months and will require recompete. SCI-reported invoiced revenue across FY2022–FY2024 totaled $583 thousand, with roughly 0.2 FTEs delivering federal services in both FY2022 and FY2024; on federal services contracts captured in SCI, government-paid median rates ran around $617/hr, with senior labor pricing through $715/hr. The vendor operates primarily as a specialized testing laboratory with no material subcontractor engagement or downstream team build.
Contract vehicles
Quick answers
What is Element Materials Technology Iowa City Inc.'s UEI?
Element Materials Technology Iowa City Inc.'s Unique Entity ID (UEI) in SAM.gov is GAJDDSFFPD89.
What is Element Materials Technology Iowa City Inc.'s CAGE code?
Element Materials Technology Iowa City Inc.'s CAGE code is 7RGU7.
What is Element Materials Technology Iowa City Inc.'s primary NAICS code?
Element Materials Technology Iowa City Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Element Materials Technology Iowa City Inc. located?
Element Materials Technology Iowa City Inc.'s physical address in SAM.gov is 345 Beaver Kreek Center, North Liberty, IA 52317, USA.
Is Element Materials Technology Iowa City Inc. registered in SAM.gov?
Yes. Element Materials Technology Iowa City Inc.'s SAM.gov registration is active through July 24, 2027.
Which contract vehicles does Element Materials Technology Iowa City Inc. hold?
Element Materials Technology Iowa City Inc. holds a place on 1 federal contract vehicle: IVAAA.
What is Element Materials Technology Iowa City Inc.'s most recent federal award?
Element Materials Technology Iowa City Inc.'s most recent federal contract award is 75N93019D00011; jones microbiology institute INC; A30: bacterial in vitro screening; to 75N93026F00001; can 8023349;… (75N93026F00001), from National Institute of Allergy and Infectious Diseases, on January 14, 2025.
On GovTribe
See Element Materials Technology Iowa City Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors